Mimedx (MDXG) Other Non-Current Assets (2010 - 2026)
Mimedx (MDXG) reported Other Non-Current Assets of $6.9 million for Q1 2026, up 557.06% on a YoY basis from $1.0 million in Q1 2025, and down 5.33% sequentially from $7.3 million in Q4 2025.
Mimedx (MDXG) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Other Non-Current Assets data on file, last reported at $6.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 557.06% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 557.06% YoY), and the FY2025 full-year result was $7.3 million, up 8.37% from the prior year.
- Other Non-Current Assets retreated to $6.9 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $7.3 million in Q4 2025 to a low of $146000.0 in Q2 2023.
- A 5-year average of $1.9 million and a median of $1.0 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 84.6% in 2023 and soared 3174.15% in 2024, its largest moves.
- Tracing MDXG's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then sank by 84.6% to $205000.0 in 2023, then soared by 3174.15% to $6.7 million in 2024, then advanced by 8.37% to $7.3 million in 2025, then dropped by 5.33% to $6.9 million in 2026.
- Business Quant data shows MDXG's Other Non-Current Assets at $6.9 million in Q1 2026, $7.3 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 6.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 990,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 205,000.00 |
| Sep 30, 2023 | 149,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Mar 31, 2023 | 147,000.00 |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 270,000.00 |
| Jun 30, 2021 | 313,000.00 |